Stephan Beck, Editor of Cancer Epigenetics

By |2017-11-13T13:37:09+01:00September 6th, 2017|News|

The Cancer Epigenetics Society is happy to announce the appointment of Dr. Stephan Beck to the Editorial Board of Cancer Epigenetics. Dr. Stephan Beck is Professor of Medical Genomics at University College London Cancer Institute (London, UK), and is one of the pioneers and a leader of the field of epigenomics. [...]

Appointment of Cigall Kadoch, Editor of Cancer Epigenetics

By |2017-07-12T10:39:35+01:00July 12th, 2017|News|

The Cancer Epigenetics Society is very happy to announce the appointment of Dr. Cigall Kadoch to the Editorial Board of the Cancer Epigenetics journals series. Dr. Kadoch is an expert of ATP-dependent mammalian SWI/SNF chromatin remodeling machineries, with a particular interest in locus-specific and genome-wide modulation by BAF complexes in cancer. Dr. Kadoch is Assistant [...]

Appointment of Lucy Godley, Editor of Cancer Epigenetics

By |2017-07-12T10:40:17+01:00July 10th, 2017|News|

The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Lucy Godley to the Editorial Board of the Cancer Epigenetics journals series. Dr. Godley is an expert of myeloid malignancies with a particular interest in DNA methylation and hydroxymethylation role in normal and neoplastic hematopoiesis. She also uses transgenic mouse models to [...]

Appointment of Peter-Jones, Editor-in-Chief at CE

By |2017-05-19T11:28:43+01:00March 13th, 2017|News|

The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Peter Jones, Chief Scientific Officer of Van Andel Research Institute (VARI, Grand Rapids, MI, USA), as co-Editor-in-Chief of the Cancer Epigenetics journal series. Dr. Jones is a world renown DNA methylation expert who was first to show that 5-azacytidine is a demethylating [...]

Appointment of Jerry Workman, Editor at CE

By |2017-05-19T11:28:43+01:00March 8th, 2017|News|

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Jerry Workman to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Workman is an Investigator at the Stowers Institute for Medical Research (Kansas City, MO, USA). Prior to his current position, Dr. Workman was a Fellow at Harvard University [...]

Appointment of Sharon Dent, Editor-in-Chief at CE

By |2017-02-24T20:57:11+01:00February 21st, 2017|News|

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Sharon Y. R. Dent to the position of co-Editor-in-Chief of the Cancer Epigenetics (CE) journal series. Dr. Dent is Professor and holds the J. Ralph Meadows Chair of the Department of Epigenetics and Molecular Carcinogenesis at University of Texas MD Anderson Cancer [...]

Appointment of Tatiana Kutateladze, Editor at CE

By |2017-02-21T20:42:35+01:00January 9th, 2017|News|

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Tatiana Kutateladze to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Kutateladze is a Professor of Pharmacology at the University of Colorado School of Medicine (Aurora, CO, USA). Her research interests include studying epigenetic mechanisms, posttranslational histone modifications, and [...]

Appointment of Luciano Di Croce, Editor at CE

By |2016-12-21T23:31:53+01:00December 21st, 2016|News|

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Luciano Di Croce to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Di Croce is the Leader of Epigenetics Events in Cancer Group at the Centre for Genomic Regulation (CGR), an international biomedical research institute of excellence at the [...]

Appointment of Jonathan D. Licht, MD, Editor at CE

By |2016-12-03T13:21:37+01:00November 28th, 2016|News|

The Cancer Epigenetics Society officially appoints Dr. Jonathan D. Licht, Editor at Cancer Epigenetics (CE) journal series. Dr. Licht is Director of University of Florida Health Cancer Center (Gainesville, FL, USA), and holds the Marshall E. Rinker Sr. Foundation and David B and Leighan R. Rinker Chair. Before that, Dr. Licht was Chief of Hematology/Oncology and [...]

Go to Top